Lord’s Mark Secures Global HIV Test Approval

Lord’s Mark Industries Ltd. obtained Central Licensing Authority approval (Licence No. MFG/IVD/2023/000058) for its LordsMed HIV 1&2 Self Test.
The approval makes Lord’s Mark the second Indian and one of nine global firms cleared to export a Class D IVD self‑test.
Exports will begin June 2026 targeting Africa, Europe and Latin America, markets expected to drive HIV self‑testing market to $600‑650 million by 2033.
Managing Director Sachidanand Upadhyay said the clearance underscores India’s growing role in global healthcare and the company’s commitment to quality and accessibility.